Siavash
In This Issue
SAVI SCOUT Receives FDA Clearance!
Best of BrachyBytes: 2014 in Review
Happy Holidays
BrachyBytes Editorial Advisory Board

Robert Kuske, M.D.

Jay Reiff, Ph.D.
Dan Scanderbeg, Ph.D.
Catheryn Yashar, M.D.
Vic Zannis, M.D.

Become a Center of Excellence in APBI

Learn about becoming a Center of Excellence and find ways to grow your APBI program by reaching out to referring physicians and women in the community.

Contact info@ciannamedical.com for more information.  
Follow-up Links

Past Issues
Cianna Medical

BEST Forum
SAVI Sisters

Nov/Dec 2014  

SAVI SCOUT Receives FDA Clearance!
In a Press Release shared last week, Cianna Medical, Inc. proudly announced the U.S. Food and Drug Administration clearance for the newest addition to our family of products, the SAVI SCOUT® surgical guidance system. This system uses non-radioactive, electromagnetic wave technology to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures.
 
If you are interested in learning more, click on the image of the system below to be directed to the recently added SAVI SCOUT page on the Cianna Medical website. Feel free to sign up and receive updates on this exciting new technology.

Best of BrachyBytes: 2014 in Review
It’s that time of year again… time to deck the halls, trim the trees and catch up on our favorite BrachyBytes articles of 2014. A heartfelt thank you to all the physicians who contributed their expertise to our newsletter. This past year was a very exciting time for breast brachytherapy, and we were happy to share all the biggest news with our dedicated subscribers. Look for the star to find our top 3 most read articles of the year!

Closing the Knowledge Gap about Breast Cancer Treatment Options

January

Radiation oncologist Catheryn Yashar, MD, of the University of California, San Diego, discusses a national survey conducted by the BC5 Project, a group focused on broadening awareness of breast cancer treatment options, and what the results mean for women and physicians.

The Link Between Cardiac Toxicity & Radiation Therapy

February

Radiation oncologist Eugene Chung, MD, of the University of Southern California Norris Cancer Center, discusses the current data on cardiac toxicity following radiation therapy for breast cancer, as well as how newer technologies, like brachytherapy, allow physicians to minimize cardiac dose.

Money Talks: 2014 Reimbursement Changes

March

Kathy Francisco of The Pinnacle Health Group, one of the nation’s leading reimbursement consulting groups, and breast surgeon Mark Gittleman, MD, discuss the changes issued by the Centers for Medicare & Medicaid Services, and the impact they have on hospitals, individual practitioners and – most importantly – patients.

 

Marketing Ahead of Science: IORT for Early-Stage Breast Cancer

April

Radiation oncologist Atif Khan, MD, of The Cancer Institute of New Jersey, New Brunswick, NJ, shares his views on IORT, the reasons behind its rapid adoption, and how the recently published data does not support a role for IORT in the management of early-stage breast cancer.

 

Is Patient Selection Criteria for APBI Outdated?

May

Radiation oncologist John Hayes, Jr., MS, MD, of Gamma West Cancer Services, Salt Lake City, Utah, discusses his views on patient selection for breast brachytherapy, including recently published data on DCIS patients and why he calls the ASTRO guidelines “quite dated.”

Is Breast Brachytherapy Still Relevant?

June

Radiation oncologist Robert Kuske, MD, FAACE, at Arizona Breast Cancer Specialists in Scottsdale, Ariz., shares his views on why overwhelming evidence supports breast brachytherapy as a standard of care for early-stage breast cancer.  

An End to Controversy: Optimal Margin Width in Breast Conserving Therapy

July/August

Radiation oncologist Siavash Jabbari, MD, of Sharp Healthcare, San Diego, Calif., discusses the significance of the new guidelines, how they’ve influenced his practice, and his thoughts on ideal margins for delivering breast brachytherapy.

Strut-based Brachytherapy with SAVI: Favorable Outcomes at 5 Years

September

Radiation oncologist Catheryn Yashar, MD, of UC San Diego’s Moores Cancer Center in La Jolla, Calif., is the co-principal investigator of the SCRG. She discusses the data, the study’s significance, and why she believes strut-based brachytherapy is the optimal method for delivering accelerated partial breast irradiation (APBI).

Getting the Best Outcomes with Oncoplastic Surgery and Breast Brachytherapy

October

Breast surgeon Pat Whitworth, MD, of the Nashville Breast Center, shares his approach to oncoplastic surgery, including why a majority of women benefit from a combination of what he calls “minor” oncoplastic techniques and targeted radiation like brachytherapy.

 

from

Cianna Medical, Inc.